The present invention provides benzamide inhibitors of the P2X7 receptor of the formula (I), wherein R1 -R3 are as defined herein. The compounds of the invention are useful in the treatment of IL-1 mediated disorders, including, without limitation, inflammatory diseases such as osteoarthritis and rheumatoid arthritis; allergies, asthma, COPD, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.
本发明提供了P2X7受体的苯甲酰胺
抑制剂,其
化学式为(I),其中R1-R3如本文所定义。本发明的化合物在治疗IL-1介导的疾病方面具有用途,包括但不限于炎症性疾病,如骨关节炎和类风湿关节炎;过敏,哮喘,慢性阻塞性肺病,癌症,再灌注或缺血性中风或心脏病发作,自身免疫疾病和其他疾病。